Latest News:
  • Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange
  • CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Patients
  • BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders
  • Nextech AR Signs Poly Deal
  • Ready for New Cannabis and Psychedelics Boom Ahead: CEOs of Aphria, Icanic Brands, Red Light Holland, and Tilray Discuss New Global Market Opportunities

Stock Day Media

Ticker Tape by TradingView

  • News
  • Radio Show
    • Be on our Show!
    • Video Interviews
  • Technology
  • Cannabis
  • Energy
  • BioTech
  • Mining
  • Contact Us
    • About Us
    • Suggestion Box
Subscribe to the latest in penny stock micro-cap news and stock podcasts, straight to your inbox.
Subscribe Now

roofing

Energy 

Solar Integrated Roofing Sees Record $3.3 Million Revenues Third Quarter-To-Date, Over 50% Increase Year-Over-Year

November 18, 2020November 18, 2020 Stock Day Media 437 Views roofing, SIRC, Solar, solarpanels, solarroofin

EL CAJON, CA / ACCESSWIRE / November 18, 2020 / Solar Integrated Roofing Corp. (OTC PINK:SIRC), an integrated, single-source solar power and

Read more
Top 5 Penny Stock Picks

Latest News

Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange
BioTech 

Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange

January 15, 2021 Stock Day Media Comments Off on Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange

NEW YORK, NY, Jan. 15, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue

CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Patients
BioTech 

CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Patients

January 15, 2021 Stock Day Media Comments Off on CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Patients
BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders
BioTech 

BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders

January 15, 2021 Stock Day Media Comments Off on BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders
Nextech AR Signs Poly Deal
Technology 

Nextech AR Signs Poly Deal

January 15, 2021 Stock Day Media Comments Off on Nextech AR Signs Poly Deal
Copyright © 2021 Stock Day Media. All rights reserved.